Portal de investigação
Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Matos, R
- Taillieu, E
- De Bruyckere, S
- De Witte, C
- Rema, A
- Nogueiro, J
- Haesebrouck, F
- Amorim, I
- Gaertner, F
Unidades de investigação
Abstract
The genus Helicobacter is composed of bacteria that colonize both the human and animal gastrointestinal tract. Helicobacter pylori infects half of the world's population, causing various disorders, such as gastritis, duodenitis and gastric cancer. Additionally, non-Helicobacter pylori Helicobacter species (NHPH) are commonly found in the stomach of pigs, dogs and cats. Most of these species have zoonotic potential and prevalence rates of 0.2-6.0%, and have been described in human patients suffering from gastric disorders undergoing a gastric biopsy. The aim of this study was to determine the occurrence of Helicobacter spp. in the stomach of patients with gastric cancer (n = 17) and obese (n = 63) patients. Furthermore, the outcome of the Helicobacter eradication treatment and the current infection status was evaluated. Overall, based on the genus-specific PCR followed by sequencing, DNA from Helicobacter spp. was detected in 46.3% of the patients, including single infections with H. pylori in 43.8% of the patients and mixed infections with H. pylori and canine- or feline-associated H. felis in 2.5%. About 32.5% of the patients had been subjected to previous Helicobacter eradication therapy and the triple standard therapy was the most frequent scheme (42.3%). In 48.0% of the patients who received eradication treatment, bacteria were still detected, including one mixed infection. In 23.1% of the patients who reported that a subsequent test had been performed to confirm the elimination of the bacteria, Helicobacter were still detected. In conclusion, although in a smaller percentage, NHPH may also be present in the human stomach. Thus, specific NHPH screening should be included in the diagnostic routine. The continued presence of H. pylori in the stomach of patients recently subjected to eradication schemes raises questions about the efficacy of the current Helicobacter treatments.
Dados da publicação
- ISSN/ISSNe:
- 2075-4426, 2075-4426
- Tipo:
- Article
- Páginas:
- 181-
- DOI:
- 10.3390/jpm12020181
- Link para outro recurso:
- www.scopus.com
Journal of Personalized Medicine Multidisciplinary Digital Publishing Institute (MDPI)
Citações Recebidas na Web of Science: 6
Citações Recebidas na Scopus: 4
Documentos
- Não há documentos
Filiações
Keywords
- Helicobacter; NHPH; human stomach; gastric disease; eradication treatment
Campos de estudo
Financiamento
Proyectos asociados
Impact of Platelet-Lymphocyte Ratio (PLR) in the prognosis of Gastric Cancer patients
Investigador Principal: Hugo Miguel Teixeira Ferraz Santos Sousa
Estudo Clínico Académico (PLR) . 2020
Impact of serum albumin concentration and neutrophil-lymphocyte ratio score on gastric cancer prognosis
Investigador Principal: Hugo Miguel Teixeira Ferraz Santos Sousa
Estudo Clínico Académico (gastric cancer prognosis . 2020
Nutritional deficiencies in bariatric surgery patients: a comparison between Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
Investigador Principal: Hugo Miguel Teixeira Ferraz Santos Sousa
Estudo Clínico Académico . 2021
Expression of Thomsen-Friedenreich Antigen in colorectal cancer and association with microsatellite instability
Investigador Principal: Celso Albuquerque Reis
Estudo Clínico Académico . 2021
The role of hepatocyte apoptosis markers in predicting the histological and serological activity in steatohepatitis
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2021
Roux-en-Y Gastric Bypass and Sleeve Gastrectomy as Revisional Bariatric Procedures after Adjustable Gastric Banding: a retrospective cohort study
Investigador Principal: Hugo Miguel Teixeira Ferraz Santos Sousa
Estudo Clínico Académico (Gastric Bypass) . 2021
High-Sensitivity modified Glasgow Prognostic Score (HS-mGPS) as a predictor of overall survival in gastric cancer patients submitted to curative-intent surgery
Investigador Principal: Hugo Miguel Teixeira Ferraz Santos Sousa
Estudo Clínico Académico . 2020
Gastric Cancer Morphological, Immunophenotypic and molecular heterogeneity
Investigador Principal: Maria de Fátima Machado Henriques Carneiro
Estudo Clínico Académico . 2020
Citar a publicação
Matos R,Taillieu E,De Bruyckere S,De Witte C,Rema A,Santos H,Nogueiro J,Reis CA,Carneiro F,Haesebrouck F,Amorim I,Gaertner F. Presence of <i>Helicobacter</i> Species in Gastric Mucosa of Human Patients and Outcome of <i>Helicobacter</i> Eradication Treatment. J. Pers. Med. 2022. 12. (2):p. 181-181. IF:3,508. (2).
